Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 461
Immune Disorders Drugs 195
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 116
Endocrine and Metabolic Disorders Drugs 103
Central Nervous System Drugs 102
Drug Discovery 101
Musculoskeletal Disorders Drugs 92
Pharmaceuticals 89
Clinical Trials 89
Hematological Drugs 83
Leukemia Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 63
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 49
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 25
Bladder Cancer Drugs 24
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

2,373 Results (Page 51 of 119)
- Relevance
  Sort by

Neuropathic Pain Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
101 Pages
Global

From

€3500EUR$4,064USD£3,059GBP

Microbiome Collaboration and Licensing Deals 2016-2026

 Report
May 2026
200 Pages
Global

From

€3686EUR$3,995USD£3,112GBP

Biologics API Market: Trends and Forecast Til 2035 - Distribution Type of Modality, Type of Expression System, Type of Bioreactor, Scale of Operation, Type of Manufacturer, and Geographical Regions

 Report
June 2026
209 Pages
Global

From

€4428EUR$4,799USD£3,739GBP

T-cell lymphoma Market - Global Forecast 2026-2032

 Report
September 2026
184 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Drugs for Benign Prostatic hypertrophy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4143EUR$4,490USD£3,498GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Prostate Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4143EUR$4,490USD£3,498GBP

Metastatic Prostate Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2768EUR$3,000USD£2,337GBP

Lymphoma Therapeutics Market - Global Forecast 2026-2032

 Report
September 2026
191 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Non-Hodgkin Lymphoma Treatment Market - Global Forecast 2026-2032

 Report
September 2026
184 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Biopharmaceutical Contract Manufacturing Market (7th Edition) by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, Therapeutic Area, and Geographical Regions - Trends and Forecast Till 2035

 Report
July 2026
575 Pages
Global

From

€4428EUR$4,799USD£3,739GBP

Hodgkin Lymphoma Treatment Market - Global Forecast 2026-2032

 Report
September 2026
186 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Advanced Parenteral Drug Delivery Devices Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Product Type

 Report
February 2022
93 Pages
Global

From

€3200EUR$3,715USD£2,797GBP

Lymphoma Treatment Market Report by Type, Test Type, Drug, and Region 2026-2034

 Report
May 2026
143 Pages
Global

From

€3690EUR$3,999USD£3,116GBP

Waldenstrom's Macroglobulinemia (WM) Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
110 Pages
Global

From

€4382EUR$4,750USD£3,701GBP

Systematic Lupus Erythematosus Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
111 Pages
Global

From

€3500EUR$4,064USD£3,059GBP

Antidotes Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4143EUR$4,490USD£3,498GBP

Non-Hodgkin Lymphoma Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
112 Pages
Global

From

€4382EUR$4,750USD£3,701GBP

Global Hodgkin Lymphoma Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
110 Pages
Global

From

€4382EUR$4,750USD£3,701GBP

Castleman Disease Treatment Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Regional Outlook and Forecast, 2022 - 2028

 Report
November 2022
226 Pages
Global

From

€3321EUR$3,600USD£2,805GBP

2,373 Results (Page 51 of 119)
- 1
- 49
- 50
- 51
- 52
- 53

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.